Results 141 to 150 of about 21,385 (196)

Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent manner. [PDF]

Cardiovasc Res
Wang Y, Li G, Chen B, Shakir G, Volz M, van der Vorst EPC, Maas SL, Geiger M, Jethwa C, Bartelt A, Li Z, Wettich J, Sachs N, Maegdefessel L, Nazari Jahantigh M, Hristov M, Lacy M, Lutz B, Weber C, Herzig S, Guillamat Prats R, Steffens S.   +21 more
europepmc   +1 more source

Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay. [PDF]

Sci Rep
Andersen HK, Vardakas DG, Lamothe JA, Perault TEA, Walsh KB, Laprairie RB.   +5 more
europepmc   +1 more source

Hepatic CB1 receptor signaling triggers G_i/oα-mediated lipolysis in lean mice but G_sα-mediated lipogenesis in obese mice. [PDF]

Metabolism
Liu J, Oliverio A, Godlewski G, Kočvarová R, Arif M, Basu A, Guan Y, Feng D, Puhl HL, Iyer MR, Cinar R, Gao B, Tam J, Kunos G.   +13 more
europepmc   +1 more source

Effect of CB1 Receptor Deficiency on Mitochondrial Quality Control Pathways in Gastrocnemius Muscle. [PDF]

Biology (Basel)
Senese R, Petito G, Silvestri E, Ventriglia M, Mosca N, Potenza N, Russo A, Manfrevola F, Cobellis G, Chioccarelli T, Porreca V, Mele VG, Chianese R, de Lange P, Ricci G, Cioffi F, Lanni A.   +16 more
europepmc   +1 more source

Effects of CB1 receptor negative allosteric modulator Org27569 on oxycodone withdrawal symptoms in mice. [PDF]

Psychopharmacology (Berl)
Scicluna RL, Everett NA, Badolato CJ, Wilson BB, Bowen MT.   +4 more
europepmc   +1 more source

Peripherally Restricted CB1 Receptor Inverse Agonist JD5037 Treatment Exacerbates Liver Injury in MDR2-Deficient Mice. [PDF]

Cells
Chen J, Li F, Lee J, Manirujjaman M, Zhang L, Song ZH, McClain C, Feng W.   +7 more
europepmc   +1 more source

In vitro CB₁ receptor activity of halogenated indazole synthetic cannabinoid receptor agonists. [PDF]

Arch Toxicol
Green H, McKenzie C, Hamra E, Rautio T, Wu X, Juneskog E, Sandblom R, Monti MC, Persson M, Norman C.   +9 more
europepmc   +1 more source

Cannabinoid CB₁ Receptor Activation Mitigates <i>N</i>‑Methyl‑d‑aspartate Receptor-Mediated Neurotoxicity. [PDF]

ACS Pharmacol Transl Sci
Navarro G, Raïch I, Rebassa JB, Lillo J, Pérez-Olives C, Capó T, Cubeles E, Saura CA, Cordomí A, Sotelo E, Reyes-Resina I, Franco R.   +11 more
europepmc   +1 more source

The interaction of Suk-Saiyasna remedy with GABAA and CB1 receptor-targeting drugs: Enhancing hypnotic and sedative effects in in vivo models. [PDF]

J Adv Pharm Technol Res
Damjuti W, Thitikornpong W, Saengow S, Thanusuwannasak T, Fuangfoo T, Boonruab J.   +5 more
europepmc   +1 more source

Pharmacological inhibition of the CB1 cannabinoid receptor restores abnormal brain mitochondrial CB1 receptor expression and rescues bioenergetic and cognitive defects in a female mouse model of Rett syndrome. [PDF]

Mol Autism
Cosentino L, Urbinati C, Lanzillotta C, De Rasmo D, Valenti D, Pellas M, Quattrini MC, Piscitelli F, Kostrzewa M, Di Domenico F, Pietraforte D, Bisogno T, Signorile A, Vacca RA, De Filippis B.   +14 more
europepmc   +1 more source